Patients with type 2 diabetes mellitus have lower rates of nocturnal hypoglycaemia on biphasic insulin aspart (BIAsp30) than on biphasic human insulin-30 (BHI30): data from the REACH study. - McNally,PG.; Nelson,G.; Pitsch,M. (Diabetologia, 2004)